Comerica Bank Biolife Solutions Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Biolife Solutions Inc stock. As of the latest transaction made, Comerica Bank holds 14,316 shares of BLFS stock, worth $371,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,316

Previous 15,715 8.9%

Holding current value

$371,643

Previous $336,000 6.55%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.19 - $26.52 $26,846 - $37,101	-1,399 Reduced 8.9%	14,316 $358,000
Q2 2024 Aug 15, 2024	SELL	$15.14 - $22.99 $18,909 - $28,714	-1,249 Reduced 7.36%	15,715 $336,000
Q1 2024 May 15, 2024	SELL	$15.35 - $18.82 $2,947 - $3,613	-192 Reduced 1.12%	16,964 $314,000
Q4 2023 Feb 14, 2024	SELL	$8.99 - $16.86 $14,186 - $26,605	-1,578 Reduced 8.42%	17,156 $278,000
Q3 2023 Nov 21, 2023	BUY	$10.81 - $22.96 $202,514 - $430,132	18,734 New	18,734 $258,000
Q4 2022 Jan 26, 2023	SELL	$16.95 - $25.07 $99,581 - $147,286	-5,875 Reduced 22.55%	20,175 $0
Q3 2022 Oct 28, 2022	BUY	$14.64 - $26.7 $2,928 - $5,340	200 Added 0.77%	26,050 $485,000
Q2 2022 Aug 02, 2022	BUY	$10.54 - $24.2 $18,339 - $42,108	1,740 Added 7.22%	25,850 $438,000
Q1 2022 Apr 27, 2022	BUY	$20.81 - $37.29 $6,138 - $11,000	295 Added 1.24%	24,110 $548,000
Q4 2021 Feb 18, 2022	SELL	$32.99 - $58.55 $83,662 - $148,482	-2,536 Reduced 9.62%	23,815 $887,000
Q3 2021 Nov 22, 2021	BUY	$42.03 - $60.5 $1.11 Million - $1.59 Million	26,351 New	26,351 $1.12 Million

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.11B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account